Pandemic influenza vaccine (H5N1, Nanotherapeutics)

N/A

Report date: 2023/09/14 20:02:05

Base Information

Drug NamePandemic influenza vaccine (H5N1, Nanotherapeutics)

Drug Alias NameH5N1全病毒灭活疫苗pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)Pandemic Influenza Vaccine H5N1 Baxter AG

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEU

Original Approved Date2018/12/12

Country/TerritoryEU

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaN/A

Originator CompaniesNanotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesResilience Biomanufacturing Ireland Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB01